Argon Plasma Coagulation and Gastric Bypass—A Novel Solution to Stomal Dilation

被引：0
作者：
Ahmad Aly
机构：
[1] Austin Hospital,
来源：
Obesity Surgery | 2009年 / 19卷
关键词：
Gastric bypass; Argon plasma coagulation; Dilated stoma; Endoscopy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A patulous gastro-enterostomy after gastric bypass is a common cause of poor restriction and poor weight loss. Revisional surgery is an option but may be hazardous. This case report highlights the use of argon plasma coagulation by flexible endoscopy to reduce stomal size, improve restriction, and avoid revisional surgery.
引用
收藏
页码：788 / 790
页数：2
相关论文
共 33 条
[1]  
Higa KD(2007)Gastric Bypass: increased restriction for poor weight loss Surg Endosc. 21 1922-1923
[2]  
Boone K(1998)The surgical technique of the Fobi-Pouch operation for obesity (the transected silastic vertical gastric bypass) Obes Surg. 8 283-288
[3]  
Nimeri A(1988)Gastric bypass revision: Lessons learnt from 920 cases Surgery. 104 806-812
[4]  
Fobi MA(2001)Laparoscopic gastric bypass as reoperative bariatric surgery for failed open restrictive procedures Surg Endosc. 15 393-397
[5]  
Lee H(2006)A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results Gut. 55 1233-1239
[6]  
Schwartz RW(1985)The relationship of bacteremia to the length of injection needle in endoscopic variceal sclerotherapy Gastroinest Endosc. 31 243-245
[7]  
Stodel WE(1985)Fatal complication of endoscopic sclerotherapy: Serratia marcescens bacteremia with delayed esophageal perforation Gastrointest Endosc. 31 329-331
[8]  
Simpson WS(1988)Development of squamous cell carcinoma of the esophagus after endoscopic variceal sclerotherapy Am J Gastroenetrol. 83 564-568
[9]  
De Csepel J(2006)Peroral endoscopic reduction of dilated gastrojejunal anastomosis after Roux-en-Y gastric bypass: a possible new option for patients with weight gain Surg Endosc. 20 1744-1748
[10]  
Nahouraii R(2003)Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up Gut. 52 34-39
1234